Navigation Links
Aribex CEO Receives Utah Governor's Medal
Date:1/20/2011

OREM, Utah, Jan. 20, 2011 /PRNewswire/ -- D. Clark Turner, PhD, President and CEO of Aribex, Inc., was awarded the Utah Governor's Medal for Science and Technology in a ceremony Tuesday night at Discovery Gateway. Utah Governor Gary Herbert made the presentation to Dr. Turner and six others for providing distinguished service that has benefited the State of Utah.

"I am privileged and grateful to be recognized among the other accomplished individuals who are receiving this most prestigious award tonight, and I share this with the great individuals with whom I've worked over the years." said Dr. Turner. "The state of Utah provides a rich community for advancements in science and technology, and I am a beneficiary of that innovative environment."

The nomination for this award was made because of Turner's development of the NOMAD Handheld X-ray System, which fills the need for a truly portable, lightweight dental x-ray. Thousands of NOMAD devices are now in use in the finest professional offices. Unlike the bulky wall-mount systems dentists traditionally used, the NOMAD x-ray is lightweight, rechargeable, and can go anywhere.

Dr. Turner's invention has also made access to dental care possible in countless remote humanitarian clinics around the world. Hundreds of thousands of people have benefited world-wide from improved dental care on these humanitarian missions.  The device has been recognized as a runner-up in the Wall Street Journal technology innovation awards for 2010, and is rapidly becoming standard equipment in dental offices worldwide. Dr. Turner founded Aribex as a Utah corporation in 2003 to manufacture and market the device.

The Governor's Medal award program was initiated in 1987 to recognize those who have made achievements in the areas of Science and Technology. Nominations are solicited from four general categories: Academia, Science Education, Industry and Government. The Utah State Advisory Council on Science and Technology is responsible for administering the award and for recommending nominees to Governor Herbert.

Dr. Turner earned his B.S. in chemistry from Brigham Young University in 1985, and a Ph.D. in analytical chemistry from BYU in 1991. Following eight years in the semiconductor industry, he moved into 12 years of product management and business development with MOXTEK, a manufacturer of x-ray components, advancing to Chief Technology Officer. Turner developed several commercially-successful x-ray products, and worked on R&D development projects for both NASA and the European Space Agency prior to founding Aribex.  

As a recognized expert in his field, Dr. Turner has published over 20 scientific papers and has been granted 7 US patents with several patent applications pending. He is active in the Utah business community, and is a trustee with the Utah Technology Council (UTC). In 2009 he was named by the UTC as the Emerging Executive of the year. He remains close to BYU by serving on the Volunteer Leadership Council for the College of Physical and Mathematical Sciences.  

About Aribex

Aribex, Inc. has quickly become recognized as the worldwide leader in innovative handheld X-ray products. Aribex is a privately owned, Orem, Utah-based company founded in 2003 with the mission to develop, manufacture, and market new technologies in the X-ray radiography fields. Aribex flagship products are the NOMAD and NOMAD Pro handheld X-ray systems. The NOMAD battery-powered handheld platform provides for expansion from dentistry into other X-ray imaging solutions such as veterinary, medical, industrial, and security applications. For more information, visit www.aribex.com.

NOTE: A high resolution photo of the event is available upon request.


'/>"/>
SOURCE Aribex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... Digital Health Dialog, LLC dba EngagedMedia ... US Patent and Trademark Office of U.S. Patent ... for electronic opt-­in and processing of discount coupons ... compliance and otherwise. Logo - http://photos.prnewswire.com/prnh/20160524/371583LOGO ... "Our technology allows for individuals to opt­-in to ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide a path to ... society can control and change. , As nearly 795,000 Americans suffering from a new ... United States. Plus, with an estimated 129,000 of these people dying from stroke, it’s ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, courtesy of leaders in the nursing and ... within the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... outcomes, hosted members and suppliers for its inaugural Member Conference at the Paris ... mission of elevating the operational health of America’s healthcare providers. , The conference ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at John ... a new model of care for living and healing, celebrated its grand opening, today. ... in a Real Home provided by Empowered Staff. , “This is an incredibly fulfilling ...
Breaking Medicine News(10 mins):